Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Pediatric Blood & Cancer|May 20, 2022
An evaluation of the disparities affecting the underdiagnosis of pediatric cancer in Western KenyaTyler S Severance, Festus Njuguna, Gilbert Olbara, et al.Nature Reviews. Disease Primers|May 19, 2016
RetinoblastomaHelen Dimaras, Timothy W Corson, David Cobrinik, et al.Journal of Global Oncology|November 3, 2017
Wilms Tumor Treatment Outcomes: Perspectives From a Low-Income SettingFestus Njuguna, Hugo A Martijn, Robert Tenge Kuremu, et al.JCO Global Oncology|February 11, 2026
Prospective Cohort Study Testing Interventions to Reduce Diagnosis Delay and Treatment Abandonment of Children With Burkitt Lymphoma in KenyaSandra Langat, Festus Njuguna, Nicholas Kigen, et al.Pediatric Blood & Cancer|July 3, 2024
Vincristine exposure in Kenyan children with cancer: CHAPATI feasibility studyAniek Uittenboogaard, Mirjam van de Velde, Lisa van de Heijden, et al.Pediatric Blood & Cancer|November 11, 2014
Risk factors for abandonment of Wilms tumor therapy in KenyaJaime Libes, Oliver Oruko, Fatmah Abdallah, et al.BMJ Open|March 20, 2026
Using flow cytometry for paediatric leukaemia diagnosis in Kenya: a protocol for mixed methods studyTyler Severance, Teresa Lotodo, Enock Serem, et al.Pediatric Blood & Cancer|May 10, 2018
Health-care providers' perspectives on health-insurance access, waiving procedures, and hospital detention practices in KenyaSaskia Mostert, Festus Njuguna, Renske H M van der Burgt, et al.BMJ Open|May 6, 2026
CARE study: prospective cohort study on supportive care among paediatric oncology patients in western Kenya-a study protocolAlice Gichemi, Noa Esther Wijnen, Eline Kormelink, et al.Pediatric Blood & Cancer|November 9, 2017
CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancerJodi L Skiles, ChienWei Chiang, Claire H Li, et al.Pageof 6